Article Text

other Versions

PDF
Letter
Authors’ response
  1. Rajarshi Mukherjee1,
  2. Christine A Kiire1,
  3. Neil Ruparelia2,
  4. David Keeling3,
  5. Bernard Prendergast2,
  6. Jonathan H Norris1
  1. 1Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK
  2. 2Department of Cardiology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK
  3. 3Department of Haematology, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK
  1. Correspondence to Jonathan H Norris, Oxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford OX3 9DU, UK; jonathan.norris{at}ouh.nhs.uk

Statistics from Altmetric.com

We thank Grzybowski et al for their comments on our paper.1 The main contention of the authors is that patients undergoing cataract surgery with antiplatelet (Ap) and/or anticoagulant (Ac) medications should continue to receive these drugs based on evidence in the medical literature.

In our paper, we clearly acknowledge that the predominant technique for lens extraction is phacoemulsification, and that the risk of complications related to bleeding is rare. In one of the papers2 referenced by Grzybowski et al, a small, but not insignificant, risk of intraoperative haemorrhage in patients undergoing cataract surgery is mentioned, with …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles